Barclays’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.5M | Buy |
|
|||||
|
2023
Q3 | $651K | Sell |
|
|||||
|
2023
Q2 | $594K | Buy |
|
|||||
|
2023
Q1 | $236K | Sell |
|
|||||
|
2022
Q4 | $300K | Buy |
|
|||||
|
2022
Q3 | $18K | Sell |
|
|||||
|
2022
Q2 | $398K | Buy |
|
|||||
|
2022
Q1 | $130K | Sell |
|
|||||
|
2021
Q4 | $285K | Buy |
|
|||||
|
2021
Q3 | $104K | Buy |
|
|||||
|
2021
Q2 | $40K | Sell |
|
|||||
|
2021
Q1 | $264K | Buy |
|
|||||
|
2020
Q4 | $129K | Sell |
|
|||||
|
2020
Q3 | $230K | Sell |
|
|||||
|
2020
Q2 | $415K | Sell |
|
|||||
|
2020
Q1 | $204K | Buy |
|
|||||
|
2019
Q4 | $149K | Sell |
|
|||||
|
2019
Q3 | $4.11M | Buy |
|
|||||
|
2019
Q2 | $2.87M | Buy |
|
|||||
|
2019
Q1 | $837K | Buy |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $624K | Buy |
|
|||||
|
2018
Q2 | $58K | Sell |
|
|||||
|
2018
Q1 | $1.15M | Sell |
|
|||||
|
2017
Q4 | $1.26M | Buy |
|
|||||
|
2017
Q3 | $107K | Sell |
|
|||||
|
2017
Q2 | $85K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $22K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $14K | Buy |
|